Fighting the rise of antibiotic resistance
As antibiotic resistance continues to develop worldwide, Australia is at the forefront of needing to address the challenge as the eighth highest user of antibiotics globally. The more we use antibiotics, the more chance bacteria can develop a resistance to them.
Murdoch Professor Geoffrey Coombs is leading research to detect early warning signs for potential outbreaks of drug-resistant bacteria to inform better infection control procedures in hospitals.
This research is part of the Australian Group on Antimicrobial Resistance (AGAR)’s strategy on controlling antimicrobial resistance (AMR) in collaboration with the World Health Organisation.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.